文献速递细菌感染、耐药与抗菌药物

ST14CC-PBP3 IIb/A克隆群在瑞典的传播与临床影响:一项前瞻性观察研究

The spread and clinical impact of ST14CC-PBP3 type IIb/A, a clonal group of non-typeable Haemophilus influenzae with chromosomally mediated β-lactam resistance-a prospective observational study.
PubMed 文献 · Clin Microbiol Infect · 2016-11-13

本研究在瑞典斯科讷地区前瞻性收集2010至2012年呼吸道或侵袭性流感嗜血杆菌感染患者分离株(n=3262),通过部分多位点序列分型和ftsI测序鉴定ST14CC-PBP3IIb/A克隆群。结果显示该克隆群占呼吸道rPBP3 NTHi的26%(94/360),患者住院率高于其他rPBP3 NTHi组(14/83 vs 21/255,p=0.025)和敏感NTHi组(14/83 vs 13/191,p=0.010),并呈动态地理传播。结论提示该克隆群与临床毒力增强、多重耐药及持续存在相关。

要点

  • ST14CC-PBP3IIb/A占呼吸道rPBP3 NTHi的26%,呈动态地理传播。
  • 该克隆群感染患者住院率显著高于其他rPBP3 NTHi和敏感NTHi组。
  • 该克隆群占侵袭性rPBP3 NTHi的25%(2/8),与毒力增强相关。

核心结论

  • ST14CC-PBP3IIb/A克隆群与临床毒力增强、多重耐药及持续存在相关。
  • 不同NTHi毒力存在差异,NTHi疾病可能比既往认识更依赖细菌因素。

研究设计与样本

  • 前瞻性观察研究,在瑞典斯科讷地区2010-2012年收集呼吸道或侵袭性流感嗜血杆菌感染患者分离株(n=3262)。
  • 通过部分多位点序列分型和ftsI(PBP3基因)测序鉴定ST14CC-PBP3IIb/A克隆群。
  • 分析感染类型、住院和结局数据,并调查不同组分离株的地理分布。

主要发现

  • ST14CC-PBP3IIb/A分离株占呼吸道rPBP3 NTHi的26%(n=94/360)。
  • 患者地址映射显示研究期间该克隆群呈动态地理传播。
  • ST14CC-PBP3IIb/A感染患者住院率高于其他rPBP3 NTHi(14/83 vs 21/255,p=0.025)。
  • ST14CC-PBP3IIb/A感染患者住院率高于敏感NTHi(14/83 vs 13/191,p=0.010)。
  • ST14CC-PBP3IIb/A分离株占研究期间侵袭性rPBP3 NTHi的25%(n=2/8)。

临床怎么用

  • 对rPBP3 NTHi感染患者,应考虑ST14CC-PBP3IIb/A克隆群可能且与住院风险升高相关。
  • 该克隆群多重耐药,经验性抗菌治疗需参考当地耐药监测数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Increasing incidences of non-typeable Haemophilus influenzae (NTHi) with β-lactam resistance mediated through mutations in penicillin-binding protein 3 (BLNAR or rPBP3) have been observed in the past decades. Recently, an rPBP3 NTHi sequence type (ST) 14 with PBP3 type IIb/A caused a disease outbreak in a nursing home in Sweden with severe outcomes, indicating increased bacterial virulence. In this prospective observational study, the epidemiology and clinical significance of the corresponding clonal group (ST14CC-PBP3IIb/A) in Skåne, Sweden was investigated. METHODS: ST14CC-PBP3IIb/A isolates were identified through partial multilocus sequence typing and ftsI(PBP3 gene)-sequencing of prospectively collected H. influenzae from patients with respiratory tract or invasive infections (n=3262) in 2010-2012. Data on type of infection, hospitalization and outcomes were analysed, and the geographical distribution of isolates from different groups was investigated. RESULTS: Isolates belonging to ST14CC-PBP3IIb/A constituted 26% (n=94/360) of respiratory tract rPBP3 NTHi. From mapping of patient addresses, a dynamic geographical spread was apparent during the study period. Furthermore, patients with infections by ST14CC-PBP3IIb/A isolates had higher hospitalization rates compared with patients infected with other rPBP3 NTHi (14/83 versus 21/255, p 0.025) and to a group of patients infected with susceptible NTHi (14/83 versus 13/191, p 0.010). ST14CC-PBP3IIb/A isolates constituted 25% (n=2/8) of invasive rPBP3 NTHi during the study period. CONCLUSIONS: Our investigation suggests that the ST14CC-PBP3IIb/A clonal group is associated with increased clinical virulence, resistance to several antimicrobial agents, and is persistent over time. We conclude that virulence varies between different NTHi, and that NTHi disease may be more dependent on bacterial factors than previously recognized.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Månsson V, Skaare D, Riesbeck K, et al. The spread and clinical impact of ST14CC-PBP3 type IIb/A, a clonal group of non-typeable Haemophilus influenzae with chromosomally mediated β-lactam resistance-a prospective observational study. Clin Microbiol Infect. 2016. PMID: 27852000. doi:10.1016/j.cmi.2016.11.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。